Nanalysis Scientific Corp.
NSCIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $1 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $9 | $9 | $8 | $11 |
| Inventory | $4 | $4 | $5 | $4 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $15 | $15 | $15 | $18 |
| Property Plant & Equip (Net) | $2 | $2 | $3 | $3 |
| Goodwill | $6 | $6 | $6 | $6 |
| Intangibles | $12 | $13 | $13 | $13 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $22 | $23 | $24 | $24 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $37 | $38 | $39 | $42 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $6 | $6 |
| Short-Term Debt | $11 | $11 | $10 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $1 | $1 | $1 |
| Other Curr. Liab. | $0 | $0 | $1 | $1 |
| Total Curr. Liab. | $18 | $17 | $18 | $14 |
| LT Debt | $8 | $7 | $6 | $12 |
| Deferred Rev, NC | $1 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $8 | $8 | $7 | $12 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $26 | $25 | $24 | $27 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $58 | $58 | $58 | $58 |
| Retained Earnings | -$54 | -$52 | -$50 | -$49 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $6 | $6 | $6 | $6 |
| Total Equity | $11 | $13 | $14 | $16 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $37 | $38 | $39 | $42 |
| Net Debt | $18 | $17 | $15 | $17 |